Presence and characterization of the dopamine transporter in human resting lymphocytes

Neurochemical Research

Volumn 33, Issue 6, 2008, Pages 1011-1016

  Marazziti, Donatella ^a   Baroni, Stefano ^a   Catena Dell'Osso, Mario ^a   Masala, Irene ^a   Fabbrini, Laura ^a   Betti, Laura ^a   Giannaccini, Gino ^a   Dell'Osso, Bernardo ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

3H DA reuptake; 3H WIN 35,428 binding; Dopamine; Dopamine transporter; Human lymphocytes; Pharmacological characterization

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; DOPAMINE TRANSPORTER; LIGAND; TRITIUM;

ADULT; AMINO ACID TRANSPORT; ARTICLE; CELL ISOLATION; CELL LABELING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE MEMBRANE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LYMPHOCYTES; MALE; TRITIUM;

EID: 42149133661     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9541-4     Document Type: Article

References (34)

1. Cragg SJ, Rice ME (2004) DAncing past the DAT at a DA synapse. Trends Neurosci 27(5):270-277
2. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93
3. Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295(1-3):149-154
4. Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30(1):79-87
5. Little KY, Carroll FI, Cassin BJ (1995) Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe. J Pharmacol Exp Ther 274(3):1473-1483
6. Boja JW, Carroll FI, Vaughan RA, Kopajtic T, Kuhar MJ (1998) Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Synapse 30(1):9-17
7. Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI (1999) Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409(1):38-56
8. Marazziti D, Baroni S, Fabbrini L, Italiani P, Catena M, Dell'Osso B, Betti L, Giannaccini G, Lucacchini A, Cassano GB (2006) Binding of 3H-WIN-35, 428 and 125I-RTI-121 to human platelet membranes. Neurochem Res 31(3):361-365
9. Frankhauser P, Grimmer Y, Bugert P, Deuschle M, Schmidt M, Schloss P (2006) Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci Lett 399(3):197-201
10. Lingjaerde O, Kildemo O (1981) Dopamine uptake in platelets: two different low-affinity, saturable mechanisms. Agents Actions 11(4):410-416
11. Sundram S, Dean B, Copolov DL (1994) The development of a method to measure [3H] dopamine uptake by washed platelets provides no evidence for circulating inhibitors of platelet dopamine uptake in schizophrenia. Biol Psychiatry 36(9):595-600
12. Lingjaerde O (1995) Dopamine uptake in platelets. Biol Psychiatry 38(6):416-417
13. Rotman A, Munitz H, Modai I, Tjano S, Wijsenbeek H (1980) A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients. Psychiatry Res 3(3):239-246
14. Rabey JM, Lerner A, Sigal M, Graff E, Oberman Z (1992) [3H]dopamine uptake by platelet storage granules in schizophrenia. Life Sci 50(1):65-72
15. Dean B, Sundram S, Hill C, Copolov DL (1996) Platelet [3H]dopamine uptake is differentially affected by neuroleptic drug treatment in schizophrenia and schizophreniform disorder. Prog Neuropsychopharmacol Biol Psychiatry 20(1):45-55
16. Takahashi N, Nagai Y, Ueno S, Saeki Y, Yanigihara T (1992) Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudo genes. FEBS Lett 314:23-25
17. Nagai Y, Ueno S, Saeki Y, Soga F, Yanagihara T (1993) Expression of D3 dopamine receptor gene and novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem Biophys Res Commun 194:368-374
18. Vile JM, Strange PG (1995) High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes and their relation to dopamine receptors. Biochem Pharmacol 49:747-753
19. Bondy B, De Jonge S, Pander S, Primbs J, Ackenheil M (1996) Identification of dopamine D4 mRNA in circulating lymphocytes using nested polymerase chain reaction. J Neuroimmunol 71:139-144
20. Josefsson E, Bergquist J, Ekman R, Tarkowski A (1996) Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 82:73-80
21. Musso NR, Brenci S, Setti M, Indiveri F, Lotti G (1996) Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab 81:3553-3557
22. Bergquist J, Silberring J (1998) Identification of catecholamines in the immune system by electrospray ionisation mass spectrometry. Commun Mass Spectrom 12:683-688
23. Caronti B, Tanda G, Colosino C, Ruggeri S, Calderaro C, Paladini G, Pontieri FE, Di Chiara G (1999) Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease. Neuroreport 10:2907-2910
24. Tsao CW, Lin YS, Cheng JT (1998) Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci 62:335-344
25. Faraj BA, Olkowski ZL, Jackson RT (1995) A cocaine-sensitive active dopamine transport in human lymphocytes. Biochem Pharmacol 50:1007-1014
26. 3H-dopamine uptake displayed by native lymphocyte suspension is mainly due to contaminating platelets. Pharmacopsychiatry 31:193-198
27. Amenta F, Bronzetti E, Cantalamessa F, El-Assouad D, Felici L, Ricci A, Tayebati SK (2001) Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J Neuroimmunol 117(1-2):133-142
28. Caronti B, Antonini G, Calderaro C, Ruggieri S, Palladini G, Pontieri FE, Colosimo C (2001) Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. J Neural Transm 108(7):803-807
29. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114(8):975-979
30. Marazziti D, Rossi A, Giannaccini G, Baroni S, Lucacchini A, Cassano GB (1998) Presence and characterization of the serotonin transporter in human resting lymphocytes. Neuropsychopharmacology 19(2):154-159
31. McPherson GA (1985) Kinetic, EBDA, LIGAND, Lowry: a collection of radioligand binding analysis programs. Cambridge, Biosoft
32. Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, Abraham P, Lewin AH, Boja JW, Kuhar MJ (1995) Cocaine and 3 beta-(4′-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38(2):379-388
33. Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK (2005) Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. J Pharmacol Exp Ther 314(2):575-583
34. Buttarelli FR, Circella A, Pellicano C, Pontieri FE (2006) Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis. Eur J Neurol 13(4):416-418